Research Article: Viloxazine Increases Extracellular Concentrations of Norepinephrine, Dopamine, and Serotonin in the Rat Prefrontal Cortex at Doses Relevant for the Treatment of Attention-Deficit/Hyperactivity Disorder
Abstract:
Graphical Abstract:
Introduction:
Dysregulated dopaminergic and noradrenergic neurotransmission has been widely implicated in the pathophysiology of ADHD based on the fact that most available drugs (including stimulants) act by targeting these neurotransmitter systems. A role for serotonin (-HT) in ADHD has also been delineated; however, due to the superior efficacy of psychostimulants, and the relative ineffectiveness of selective serotonin reuptake inhibitors (SSRI’s) in the treatment of ADHD, the therapeutic potential of targeting the…
Read more